# BioFreedom FIM Clinical Trial.

> **NCT01172119** · PHASE2,PHASE3 · COMPLETED · sponsor: **Biosensors Europe SA** · enrollment: 182 (actual)

## Conditions studied

- Treatment Of Stenotic Lesions In Native Coronary Arteries.

## Interventions

- **DEVICE:** Biofreedom Drug Eluting Stent
- **DEVICE:** Biofreedom Drug Eluting Stent
- **DEVICE:** Tuxus Liberte Drug Eluting Stent

## Key facts

- **NCT ID:** NCT01172119
- **Lead sponsor:** Biosensors Europe SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-06
- **Final completion:** 2014-07
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2014-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01172119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01172119, "BioFreedom FIM Clinical Trial.". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT01172119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*